15 weeks to go - World Orphan Drug Congress USA 2016

15 weeks until the only global gathering for the rare disease industry

In Orphan Drug Congress, Orphan Drugs Live by Freya SmaleLeave a Comment

The rare disease industry’s only global gathering returns for its 6th year, bigger and better than ever. Terrapinn invites you to the World Orphan Drug Congress USA, a commercially-focused global meeting for biotechs, pharma developing orphan drugs together with rare disease patient groups, payers, and regulators.

Event details:

  • 2 days of conference content
  • A pre-conference workshop day on April 20th with 8 workshops and 2 full day seminars for you to choose from*
  • 800+ industry stakeholders all gathered under one roof
  • 150+ speakers- all industry leaders providing perspectives from around the world
  • 50+ sponsors offering solutions to suit your business needs

Download the brochure now to see the full agenda >

We are thrilled to announce our speaker line-up, which includes industry leaders from across Academic Medical Centers/ Hospitals, Industry, Government Institutions, Patient (Advocacy Groups), Regulators, Solution Providers/Experts, Payers and Associations.

Our 2016 speaking faculty includes:

  • Emil Kakkis, President & CEO, Ultragenyx 
  • Richard Moscicki, Deputy Center Director for Science Operations, Center for Drug Evaluation and Research, FDA 
  • Art Caplan, Head, Division of Medical Ethics, NYU Langone Medical Center 
  • Steven Ryder, Senior Vice President and Chief Development Officer, Alexion 
  • Bruno Sepodes, Chair, Committee for Orphan Medicinal Products (COMP), European Medicines Agency (EMA) 
  • Mark Baglin, Vice President, Product Strategy Team Leader, Angioedema Franchise, Rare Disease Business Unit, Shire 
  • Edmund Pezalla, Vice President, National Medical Director, Pharmacy Policy and Strategy, Aetna
  • Charles O’Neill, VP, Pharmacological Sciences, BioMarin Pharmaceutical
  • Rashmi Gopal-Srivastava, Director, Extramural Research Program, Office of Rare Diseases Research, NCATS, National Institutes of Health
  • Yann Le Cam, Chief Executive Officer, EURORDIS 
  • Peter Saltonstall, President & CEO, NORD 

For more information about their sessions and more, please download the event brochure here >

To book simply visit the website at: www.terrapinn.com/orphandrug

Keep up with all the latest WODC USA on #WODC or follow us at @OrphanConf 

WODC USA 2016

Leave a Comment